HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 41 | 42 | 97.6% | |
| HF004 | 2020 | 22 | 23 | 95.7% | |
| HF006 | 2021 | 41 | 41 | 100.0% | |
| HF006 | 2022 | 97 | 99 | 98.0% | |
| HF006 | 2023 | 85 | 94 | 90.4% |
